Vaccine News and Research

Latest Vaccine News and Research

Listeria-based booster vaccine strategy offers improved protection against recurrent colorectal cancer

Colorectal, pancreatic, esophageal and stomach cancers - some of the deadliest kinds of cancer - have high recurrence rates where the cancer comes back even after successful surgery or radiation treatment.

23 Jun 2022

The effect of immunization with bivalent oral poliovirus vaccine on the incidence of COVID-19

Researchers evaluated the impact of the OPV on the incidence of COVID-19.

23 Jun 2022

Addressing parents' hesitancy to vaccinate their children against COVID

Researchers examine notable risk factors related to vaccine hesitancy among parents.

23 Jun 2022

Correlates of anamnestic humoral immunity throughout SARS-CoV-2 variants of concern

A recent work posted to the bioRxiv* preprint server assessed the indicators of anamnestic humoral immunity among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs).

23 Jun 2022

Study shows the safety of COVID-19 vaccines for patients with cardiovascular disease

COVID-19 vaccination is not associated with an increased risk of heart attack or stroke in patients with established cardiovascular disease, according to a large study published today in Cardiovascular Research, a journal of the European Society of Cardiology.

23 Jun 2022

Analyzing biophysical restrictions of SARS-CoV-2 N-terminal domain

In a recent article posted to the bioRxiv* preprint server, researchers at the University of Illinois at Urbana-Champaign, Scripps Research Institute, and Case Western Reserve University evaluated the biophysical limitations of the spike (S) N-terminal domain (NTD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

23 Jun 2022

Paxlovid is shown to be effective in treating COVID-19

In a recent Morbidity and Mortality Weekly Report (MMWR) published on the United States Center for Disease Control and Prevention (US-CDC) website, researchers described cases of coronavirus disease 2019 (COVID-19)–related hospitalizations and emergency department (ED) visits in five to 15 days following Paxlovid (Nirmatrelvir/ritonavir ) treatment.

22 Jun 2022

Lung cancer patients treated with immune checkpoint inhibitors can be safely vaccinated against COVID-19, study says

Cancer patients have received priority status to receive COVID-19 vaccinations but there is limited data regarding the safety and efficacy of the vaccines for patients treated for lung cancer with immune checkpoint inhibitors.

22 Jun 2022

Focus on good surveillance and control measures can help Africa to curb monkeypox

African governments must focus on investing in their surveillance systems and strengthening preparedness to curb the rapid spread of infectious diseases like monkeypox, experts have said.

22 Jun 2022

A longitudinal population-based study of COVID-19 in the UK

In a recent study posted to the medRxiv* pre-print server, researchers identified potential risk factors and incident symptoms of coronavirus disease 2019 (COVID-19) in the general population of the United Kingdom (UK).

21 Jun 2022

Moderna to build large-scale mRNA manufacturing center in the UK

NHS patients will have access to the next generation of vaccines and treatments following an agreement between the government and Moderna to build a state-of-the-art manufacturing and research and development centre in the UK.

21 Jun 2022

Study finds vaccination hesitancy among parents of children with kidney disease or hypertension

In this study published in the American Journal of Kidney Diseases (AJKD), over 60% of surveyed parents of children with kidney disease or hypertension reported they were unsure or unwilling to vaccinate their child against COVID-19.

21 Jun 2022

Wistar scientists discover a new way to boost a person's immune response to tumors

Due to the development of resistance to chemotherapy and recurring tumors, patients with ovarian cancer often have low survival rates.

21 Jun 2022

Vaccination uptake found to be critical to limiting COVID-19 transmission during variant-driven surges

US states with low vaccination rates bore the brunt of the COVID-19 surge caused by the Delta variant during the summer of 2021, says a study published today in eLife.

21 Jun 2022

The effect of the COVID-19 BNT162b2 vaccine on semen parameters among semen donors

Researchers explored the impact of COVID-19 BNT162b2 (Pfizer) vaccinations on male fertility among semen donors in Israel.

21 Jun 2022

Researchers compare the development and persistence of antibody and T-cell responses elicited by the mRNA BNT162b2 vaccine or SARS-CoV-2 infection

Researchers comparatively assessed the generation of B lymphocyte-mediated antibody responses and T lymphocyte-mediated cellular responses between mRNA BNT162b vaccinees and mild COVID-19 patients.

21 Jun 2022

Only 20% of Americans have effective protection against Omicron infection

In a recent research paper published in the Clinical Infectious Diseases journal, scientists analyzed the population immunity against pre-Omicron and Omicron severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) variants in U.S. counties and states up until December 1, 2021. Background

21 Jun 2022

Each SARS-CoV-2 reinfection causes more severe disease

In a recent study under review at the Nature Portfolio journal and currently posted to the Research Square* preprint server, researchers at Washington University School of Medicine and VA Saint Louis Health Care System showed that acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection adds to the risks of all-cause mortality and hospitalization accrued during the first SARS-CoV-2 infection.

20 Jun 2022

Real-world study shows Paxlovid associated with lower hospitalization rates

In a recent study posted to the medRxiv* pre-print server, researchers investigated the effectiveness of nirmatrelvir plus ritonavir in preventing hospitalizations among individuals aged 50 or older and vaccinated for coronavirus disease 2019 (COVID-19).

20 Jun 2022

Is SARS-CoV-2 a seasonal virus?

In a recent study posted to the medRxiv* pre-print server, scientists at Pfizer Inc determined whether coronavirus disease 2019 (COVID-19) case rates in the United States (US) and European (EU) nations followed a seasonal pattern using a time series model.

20 Jun 2022

Vaccine News and Research

Latest Vaccine News and Research

Listeria-based booster vaccine strategy offers improved protection against recurrent colorectal cancer

The effect of immunization with bivalent oral poliovirus vaccine on the incidence of COVID-19

Addressing parents' hesitancy to vaccinate their children against COVID

Correlates of anamnestic humoral immunity throughout SARS-CoV-2 variants of concern

Study shows the safety of COVID-19 vaccines for patients with cardiovascular disease

Analyzing biophysical restrictions of SARS-CoV-2 N-terminal domain

Paxlovid is shown to be effective in treating COVID-19

Lung cancer patients treated with immune checkpoint inhibitors can be safely vaccinated against COVID-19, study says

Focus on good surveillance and control measures can help Africa to curb monkeypox

A longitudinal population-based study of COVID-19 in the UK

Moderna to build large-scale mRNA manufacturing center in the UK

Study finds vaccination hesitancy among parents of children with kidney disease or hypertension

Wistar scientists discover a new way to boost a person's immune response to tumors

Vaccination uptake found to be critical to limiting COVID-19 transmission during variant-driven surges

The effect of the COVID-19 BNT162b2 vaccine on semen parameters among semen donors

Researchers compare the development and persistence of antibody and T-cell responses elicited by the mRNA BNT162b2 vaccine or SARS-CoV-2 infection

Only 20% of Americans have effective protection against Omicron infection

Each SARS-CoV-2 reinfection causes more severe disease

Real-world study shows Paxlovid associated with lower hospitalization rates

Is SARS-CoV-2 a seasonal virus?

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in